News | Cath Lab | August 15, 2017

Safety-Net vs. Non-Safety-Net Hospitals Deliver Similar PCI Outcomes

NCDR CathPCI Registry data shows in-hospital mortality only marginally higher for PCIs at safety-net hospitals

NCDR CathPCI Registry data shows in-hospital mortality only marginally higher for PCIs at safety-net hospitals.

Aug. 15, 2017 – Patients undergoing percutaneous coronary intervention (PCI) at safety-net hospitals experienced similar outcomes as patients treated at non-safety-net hospitals, according to research published Aug. 7 issue of JACC: Cardiovascular Interventions. Read the abstract.

Safety-net hospitals in the U.S. serve the nation’s most vulnerable patients, with a focus on providing quality care to patients who are low income and/or uninsured or underinsured, as well as to patients who have insurance. Notably, safety-net hospitals may have fewer resources than other hospitals. In this study, a safety-net hospital was defined as having a PCI volume of at least 10 percent for patients without insurance, based on the Agency of Healthcare Quality and Research definition.

“The patients treated at safety-net hospitals often have critical heart problems and other health issues that, in many cases, have not been adequately managed,” said senior study author John Ambrose, M.D., FACC, emeritus chief of cardiology at the University of California, San Francisco (USCF-Fresno) in Fresno, and professor of medicine at UCSF. “Therefore, the fact that these hospitals are able to keep mortality rates low and achieve these outcomes when performing PCI — nearly matching non-safety net hospitals—is quite remarkable.”

The investigators used data from the American College of Cardiology’s National Cardiovascular Data Registry (NCDR) CathPCI Registry from 2009 to 2015. They analyzed data from 3,746,961 patients who underwent PCI at 282 safety-net hospitals and 1,134 non-safety-net hospitals. The results showed risk-adjusted in-hospital mortality was only marginally higher in the safety-net hospitals (at four additional patients per 1,000 cases of PCI) than in non-safety-net-hospitals. Patients who went to safety-net hospitals tended to be younger, had more risk factors and more often entered through the emergency department because of a heart attack.

The study also found that both types of hospitals had similar rates of risk-adjusted bleeding and acute kidney injury, which are adverse events associated with PCI procedures. The results of the study are limited to the events that occurred while in the hospital.

“Clinical care is often complex. Because of that, it can be hard to make comparisons to understand what type of care is contributing to a positive outcome and what isn’t,” Ambrose said. “However, with this study, we now know that the hospital itself was not a significant factor in determining how well a patient did after their PCI procedure. The similarities we found also suggested that we can use the current NCDR risk model as a foundation for future comparisons between safety-net and non-safety-net hospitals.”

In an accompanying editorial, Theodore A. Bass, M.D., said that in addition to being vulnerable, the patients studied frequently have little or no ability to select their access to health care institutions or medical providers based on quality outcomes. He added that the study is particularly timely because of the discussion about health care legislation that has the potential to substantially affect resources for safety-net hospitals.

For more information: JACC.org

 

Related ACC NCDR Data Studies:

Study Finds Significant Variability in Doctors' Angioplasty Death Rates

Radial Access, Same-Day Cardiac Procedure Could Save $300 Million Annually

New Report Highlights National Trends in Heart Disease Treatments

Better Prognosis for Some PCI Patients When Operators Perform More Procedures

Radial Access Adoption in the United States

 

Reference:

1. Tushar Acharya, Adam C. Salisbury, John A. Spertus, et al. “In-Hospital Outcomes of Percutaneous Coronary Intervention in America’s Safety Net, Insights From the NCDR Cath-PCI Registry.” JACC: Cardiovascular Interventions. Volume 10, Issue 15, August 2017 DOI: 10.1016/j.jcin.2017.05.042
 

 

 

Related Content

TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
htisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.  In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European As...